Conference Description

November 12, 2005
Camelback Inn
5402 East Lincoln Drive
Scottsdale, Arizona
(800) 582-2169

Tell a friend about this conference
Download the brochure for this conference

CME Credits 3.5*

Nonrefundable registration fee: $0.

Target Audience: Endocrinologists

Learning Objectives:
The intimate setting of the conference will maximize learning and discussion and will enable endocrinologists to learn first hand from thought leaders in their field. Among the proposed objectives will be:

1. review the incretins and endocannaboid system and their role in the pathophysiology and therapy of the metabolic syndrome and diabetes mellitus .
2. discuss the diagnosis and new therapies for diabetic neuropathy .
3. discuss the current status of inhaled insulin, insulin analogues and other delivery systems .
4. describe the controversies surrounding sub-clinical thyroid disease and review both pre- and post-operative US guided FNA and tissue markers in thyroid cancer surveillance

Agenda:

7:45–8:20 am		Continental Breakfast and Registration
8:20–8:30 am		Welcome and Introduction Phil Levy, MD
8:30–9:10 am		Diabetic Peripheral Neuropathy 2005: The Forgotten Complication Michael Pfeiffer, MD
9:10–9:50 am		Subclinical Thyroid Disease: A Clinical Perspective Gilbert Daniels. MD
9:50–10:30 am		Emerging Treatments for the Management of Type 2 Diabetes and the Metabolic Syndrome Harold Lebovitz, MD
10:30–10:50 am		Exhibits and Break
10:50–11:30 am		The Endocannabinoid System: The Impact of CB1 Receptor Blockade on the CardioMetabolic Risk Factors in Obesity and Diabetes Julio Rosenstock, MD
11:30 am–12:10 pm		Acromegaly: Medical Management as an Alternative to Surgery Lewis S. Blevins, Jr., MD
12:10–12:20 pm		Closing Remarks Phil Levy, MD

Faculty:
Lewis S. Blevins, Jr., MD
Associate Professor
Department of Medicine and Department of Neurosurgery
Co-Director of the Pituitary Center at Vanderbilt
Vanderbilt University

Gilbert Daniels, MD, FACE
Associate Professor of Medicine at Harvard Medical School and
Co-Director of the Thyroid Clinic and
Physician at the Massachusetts General Hospital

Harold Lebovitz, MD, FACE
Professor of Medicine at the Division of Endocrinology and Metabolosim/Diabetes
at the State University of New York
Health Sciences Center at Brooklyn

Michael Pfeifer, MD, MS, CDE, FACE
Senior Medical Director and Franchise Development Leader
Metabolic Diseases
Raritan, New Jersey

Julio Rosenstock, MD
Director of Dallas Diabetes and Endocrine Center
Clinical Professor of Medicine at the
University of Texas Southwestern Medical Center at Dallas

Program Planning Committee:
Chairman
Philip Levy, MD, FACE
Phoenix Endocrinology Clinic

Co-chairmen
Paul S. Jellinger, MD, FACE
Immediate Past President, American College of Endocrinology
The Center for Diabetes and Endocrine Care
University of Miami School of Medicine

Sam Lerman, MD, FACE
The Center for Diabetes and Endocrine Care
University of Miami School of Medicine

Louis Chaykin, MD
Aventura Hospital and Medical Center
Clinical Associate Professor of Medicine at Nova Southeastern University of
Medical Sciences

Educational Consultant
Catherine Waud, M.D.
Assistant Professor of Medicine
University of Massachusetts Medical School

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 3.5 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: Abbott Laboratories, Amylin, Eli Lilly & Company, Novartis, Pfizer, Solvay.